BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 28024533)

  • 1. Using chitosan nanoparticles as drug carriers for the development of a silver sulfadiazine wound dressing.
    El-Feky GS; Sharaf SS; El Shafei A; Hegazy AA
    Carbohydr Polym; 2017 Feb; 158():11-19. PubMed ID: 28024533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alginate coated chitosan nanogel for the controlled topical delivery of Silver sulfadiazine.
    El-Feky GS; El-Banna ST; El-Bahy GS; Abdelrazek EM; Kamal M
    Carbohydr Polym; 2017 Dec; 177():194-202. PubMed ID: 28962758
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A New Insight to Silver Sulfadiazine Antibacterial Dressings: Nanoparticle-Loaded Nanofibers for Controlled Drug Delivery.
    Mutlu-Ağardan NB; Tort S; Aydoğduoğlu Ş; Kıymacı ME
    AAPS PharmSciTech; 2022 Nov; 24(1):8. PubMed ID: 36451066
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel chitosan and bacterial cellulose biocomposites tailored with polymeric nanoparticles for modern wound dressing development.
    Stanescu PO; Radu IC; Leu Alexa R; Hudita A; Tanasa E; Ghitman J; Stoian O; Tsatsakis A; Ginghina O; Zaharia C; Shtilman M; Mezhuev Y; Galateanu B
    Drug Deliv; 2021 Dec; 28(1):1932-1950. PubMed ID: 34550033
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Benefit of hydrocolloid SSD dressing in the outpatient management of partial thickness burns.
    Muangman P; Muangman S; Opasanon S; Keorochana K; Chuntrasakul C
    J Med Assoc Thai; 2009 Oct; 92(10):1300-5. PubMed ID: 19845237
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparative study of wound dressings loaded with silver sulfadiazine and silver nanoparticles: In vitro and in vivo evaluation.
    Mohseni M; Shamloo A; Aghababaie Z; Afjoul H; Abdi S; Moravvej H; Vossoughi M
    Int J Pharm; 2019 Jun; 564():350-358. PubMed ID: 31028800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antimicrobial Wound Dressing Containing Silver Sulfadiazine With High Biocompatibility: In Vitro Study.
    Mohseni M; Shamloo A; Aghababaei Z; Vossoughi M; Moravvej H
    Artif Organs; 2016 Aug; 40(8):765-73. PubMed ID: 27094090
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Results of a multicenter outpatient burn study on the safety and efficacy of Dimac-SSD, a new delivery system for silver sulfadiazine.
    Deitch EA; Sittig K; Heimbach D; Jordan M; Cruse W; Kahn A; Achauer B; Finley R; Matsuda T; Salisbury R
    J Trauma; 1989 Apr; 29(4):430-4. PubMed ID: 2651681
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Control of wound infections using a bilayer chitosan wound dressing with sustainable antibiotic delivery.
    Mi FL; Wu YB; Shyu SS; Schoung JY; Huang YB; Tsai YH; Hao JY
    J Biomed Mater Res; 2002 Mar; 59(3):438-49. PubMed ID: 11774301
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Application of polycaprolactone, chitosan, and collagen composite as a nanofibrous mat loaded with silver sulfadiazine and growth factors for wound dressing.
    Nejaddehbashi F; Hashemitabar M; Bayati V; Abbaspour M; Moghimipour E; Orazizadeh M
    Artif Organs; 2019 Apr; 43(4):413-423. PubMed ID: 30311249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Baicalin, silver titanate, Bletilla striata polysaccharide and carboxymethyl chitosan in a porous sponge dressing for burn wound healing.
    Gong YR; Zhang C; Xiang X; Wang ZB; Wang YQ; Su YH; Zhang HQ
    J Integr Med; 2023 Sep; 21(5):487-495. PubMed ID: 37544834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Construction, application and biosafety of silver nanocrystalline chitosan wound dressing.
    Lu S; Gao W; Gu HY
    Burns; 2008 Aug; 34(5):623-8. PubMed ID: 18226459
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A PEGylated fibrin-based wound dressing with antimicrobial and angiogenic activity.
    Seetharaman S; Natesan S; Stowers RS; Mullens C; Baer DG; Suggs LJ; Christy RJ
    Acta Biomater; 2011 Jul; 7(7):2787-96. PubMed ID: 21515420
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of chitosan oleate ionic micelles loaded with silver sulfadiazine to be associated with platelet lysate for application in wound healing.
    Dellera E; Bonferoni MC; Sandri G; Rossi S; Ferrari F; Del Fante C; Perotti C; Grisoli P; Caramella C
    Eur J Pharm Biopharm; 2014 Nov; 88(3):643-50. PubMed ID: 25128852
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Silver sulfadiazine loaded breathable hydrogel sponge for wound healing.
    Pandey A; Momin M; Chando A
    Drug Metab Pers Ther; 2020 Aug; 35(3):. PubMed ID: 32827392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impregnation of silver sulfadiazine into bacterial cellulose for antimicrobial and biocompatible wound dressing.
    Luan J; Wu J; Zheng Y; Song W; Wang G; Guo J; Ding X
    Biomed Mater; 2012 Dec; 7(6):065006. PubMed ID: 23182757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Harnessing biocompatible nanofibers and silver nanoparticles for wound healing: Sandwich wound dressing versus commercial silver sulfadiazine dressing.
    He C; Liu X; Zhou Z; Liu N; Ning X; Miao Y; Long Y; Wu T; Leng X
    Mater Sci Eng C Mater Biol Appl; 2021 Sep; 128():112342. PubMed ID: 34474892
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antimicrobial dressing of silver sulfadiazine-loaded halloysite/cassava starch-based (bio)nanocomposites.
    da Silva GLP; Morais LCA; Olivato JB; Marini J; Ferrari PC
    J Biomater Appl; 2021 Apr; 35(9):1096-1108. PubMed ID: 33611961
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluating the Efficacy, Safety, and Tolerance of Silver Sulfadiazine Dressings Once Daily Versus Twice Daily in the Treatment of Burn Wounds.
    Lagziel T; Asif M; Born L; Quiroga LH; Duraes E; Slavin B; Shetty P; Caffrey J; Hultman CS
    J Burn Care Res; 2021 Nov; 42(6):1136-1139. PubMed ID: 34363678
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibiofilm Potential of Silver Sulfadiazine-Loaded Nanoparticle Formulations: A Study on the Effect of DNase-I on Microbial Biofilm and Wound Healing Activity.
    Patel KK; Surekha DB; Tripathi M; Anjum MM; Muthu MS; Tilak R; Agrawal AK; Singh S
    Mol Pharm; 2019 Sep; 16(9):3916-3925. PubMed ID: 31318574
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.